Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Raphael, Jon H ^a,b   Duarte, Rui V ^a,b   Southall, Jane L ^b   Nightingale, Peter ^c   Kitas, George D ^b  

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE;

ABDOMINAL PAIN; ADULT; ARTICLE; BACKACHE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FAILED BACK SURGERY SYNDROME; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; LONG TERM CARE; LOW BACK PAIN; MALE; PAIN ASSESSMENT; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VISUAL ANALOG SCALE;

EID: 84883317777     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003061     Document Type: Article

References (40)

1. Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science 1973;179: 1011-14.
2. Yaksh T, Rudy T. Analgesia mediated by a direct spinal action of narcotics. Science 1976;192: 1357-8.
3. Dickenson AH. Recent advances in the physiology and pharmacology of pain: plasticity and its implications for clinical analgesia. J Psychopharmacol 1991;5: 342-51.
4. Behar M, Magora F, Olshwang D, et al. Epidural morphine in treatment of pain. Lancet 1979;1: 527-9. (Pubitemid 9130910)
5. Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979;50: 149-51. (Pubitemid 9130744)
6. Cousins MJ, Mather LE, Glynn CJ, et al. Selective spinal analgesia. Lancet 1979;1: 1141-2. (Pubitemid 9184886)
7. Deer T, Winkelmüller W, Erdine S, et al. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation 1999;2: 55-66. (Pubitemid 29268513)
8. Grady K, Raphael JH. Intrathecal drug delivery for the management of pain and spasticity in adults; recommendations for best clinical practice. London: The British Pain Society, 2008.
9. Doleys D. Preparing pain patients for implantable technologies. In: Turk DCGatchel RJ, eds. Psychological approaches to pain management. 2nd edn. New York: Guilford Press, 2002: 334-48.
10. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981;56: 516-20. (Pubitemid 11023593)
11. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain 2004;109: 242-9. (Pubitemid 38638700)
12. Duarte RV, Raphael JH, Sparkes E, et al. Long-term intrathecal drug administration for chronic nonmalignant pain. J Neurosurg Anesthesiol 2011;24: 63-70.
13. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010(1):CD006605.
14. Hayek SM, Deer TR, Pope JE, et al. Intrathecal therapy for cancer and non-cancer pain. Pain Physician 2011;14: 219-48.
15. McQuay H, Moore RA, Eccleston C, et al. Systematic review of outpatient services for chronic pain control. Health Technol Assess 1997;1:i-iv, 1-135.
16. Smith T, Staats P, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20: 4040-9.
17. Follett K, Naumann C. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000;19: 209-15. (Pubitemid 30173235)
18. Deer TR, Levy R, Prager J, et al. Polyanalgesic Consensus Conference - 2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation 2012;15: 467-82.
19. Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain 2007;23: 180-95. (Pubitemid 46145465)
20. Yaksh TL, Hassenbusch SJ, Burchiel K, et al. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002;3: 300-12. (Pubitemid 36040732)
21. Raphael JH, Gnanadurai T, Southall J, et al. Placebo-controlled single blind study of short-term efficacy of spinal morphine in chronic non-malignant pain. Reg Anesth Pain Med 2006;31:47.
22. Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2012;15: 436-64.
23. Van Dongen RT, Crul BJ, De Bock M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain 1993;55: 119-23. (Pubitemid 23300823)
24. Duarte RV, Raphael JH, Haque MS, et al. A predictive model for intrathecal opioid dose escalation in chronic noncancer pain. Pain Physician 2012;15: 363-9.
25. Price DD, McGrath PA, Rafii A, et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17: 45-56. (Pubitemid 13004473)
26. Fairbank JC, Couper J, Davies JB, et al. The Oswestry low back pain disability questionnaire. Physiotherapy 1980;66: 271-3. (Pubitemid 11234479)
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67: 361-70. (Pubitemid 13098606)
28. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983;17: 33-44. (Pubitemid 13004472)
29. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983;16: 87-101. (Pubitemid 13084857)
30. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9: 105-21. (Pubitemid 351147828)
31. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine 2000;25: 2940-52.
32. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52: 69-77. (Pubitemid 34192886)
33. Snow-Turek AL, Norris MP, Tan G. Active and passive coping strategies in chronic pain patients. Pain 1996;64: 455-62. (Pubitemid 26180151)
34. Bennett G, Serafini M, Burchiel K, et al. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000;20:S12-36.
35. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104: 570-87.
36. Rauck RL, Wallace MS, Leong MS, et al. A randomised, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006;31: 393-405.
37. Winkelmüller M, Winkelmüller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85: 458-67. (Pubitemid 26278029)
38. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol 2001;55: 79-86. (Pubitemid 32297679)
39. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11: 71-80. (Pubitemid 26073492)
40. Atli A, Theodore BR, Turk DC, et al. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med 2010;11: 1010-16.